Literature DB >> 31369353

Effects of Nesfatin-1 on Food Intake and Hyperglycemia.

Gülin Öztürk Özkan1.   

Abstract

Nesfatin-1 is a peptide derived from nucleobindin-2 and involved in the regulation of food intake and hyperglycemia. Nesfatin-1 is a recently described anorexigenic peptide, which may be involved in weight loss, malnutrition, and the regulation of appetite. Nesfatin-1 has an effect on the regulation of glucose homeostasis as well as that of food intake. The aim of this article is to bring a different perspective to the readers on the effects of nesfatin-1 on food intake and hyperglycemia. The central injection of nesfatin-1 may produce anorexigenic effects. The circulating level of nesfatin-1 is thought to be regulated by nutritional status. Long-term changes in body weight can affect nesfatin-1 levels. In overweight and obese individuals, nesfatin-1 levels may increase. Nesfatin-1 is synthesized in the hypothalamic appetite control regions. Nesfatin-1 levels may decrease in individuals with diabetes but may increase in those with impaired glucose tolerance. Nesfatin-1 may have a reducing effect on glucose levels. In addition, an increase in glucose levels may lead to an increase in the release of nesfatin-1 from pancreatic cells. Injection of nesfatin-1 can prevent hepatic glucose formation and stimulate glucose uptake. Reduction of hypothalamic nesfatin-1 levels increases hepatic glucose flow and decreases glucose uptake from peripheral tissues. In the light of all this information, nesfatin-1 may be considered to be an important regulator in the metabolic process. Nesfatin-1 appears to be able to contribute to the treatment of obesity and diabetes because of its anorexigenic and antihyperglycemic effects. Key teaching pointsNesfatin-1 is a anorexigenic peptide.Nesfatin-1 is derived from Nucleobindin-2.Nucleobindin-2 mRNA is produced in different areas of the brain.Nesfatin-1 is an inhibitory factor on appetite and a regulator of energy balance that reduces the increase in body weight.

Entities:  

Keywords:  Nesfatin-1; anorexigenic peptide; food intake; hyperglycemia; obesity

Mesh:

Substances:

Year:  2019        PMID: 31369353     DOI: 10.1080/07315724.2019.1646678

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  6 in total

1.  Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial.

Authors:  Saber Jafari-Maskouni; Mansour Shahraki; Milad Daneshi-Maskooni; Alireza Dashipour; Ali Shamsi-Goushki; Zinat Mortazavi
Journal:  Nutr Metab (Lond)       Date:  2020-08-26       Impact factor: 4.169

2.  Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway.

Authors:  Zhanwei Fan; Jianjiang Dong; Yindong Mu; Xian Liu
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

3.  Nesfatin-1 alleviated lipopolysaccharide-induced acute lung injury through regulating inflammatory response associated with macrophages modulation.

Authors:  Hongbing Cheng; Yanfang Zhu; Liangji Chen; Yalan Wang
Journal:  J Cardiothorac Surg       Date:  2022-08-26       Impact factor: 1.522

Review 4.  The molecular signaling of exercise and obesity in the microbiota-gut-brain axis.

Authors:  Filipe M Ribeiro; Maycon A Silva; Victória Lyssa; Gabriel Marques; Henny K Lima; Octavio L Franco; Bernardo Petriz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

5.  A Randomized Controlled Trial on the Effects of 12 Weeks of Aerobic, Resistance, and Combined Exercises Training on the Serum Levels of Nesfatin-1, Irisin-1 and HOMA-IR.

Authors:  Sasan Amanat; Ehsan Sinaei; Mohammad Panji; Reza MohammadporHodki; Zahra Bagheri-Hosseinabadi; Hadis Asadimehr; Mohammad Fararouei; Aria Dianatinasab
Journal:  Front Physiol       Date:  2020-10-16       Impact factor: 4.566

Review 6.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.